| NCT ID | NCT06092385 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Basel, Switzerland |
| Condition | Liver Cirrhosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 3,000 participants |
| Start Date | 2024-06-04 |
| Primary Completion | 2033-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 3,000 participants in total. It began in 2024-06-04 with a primary completion date of 2033-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a national prospective long-term multicentre observational cohort study following patients with cirrhosis in order to systematically and longitudinally record epidemiological, clinical, histological, psychosocial and patient-reported data and biobank biological material from patients with cirrhosis. The central element of all scientific operation and productivity in the Swiss Cirrhosis Cohort Study (SSCiCoS) is the so-called "nested project" (NP). Based on the evolving large pool of data and biological samples, SSCiCoS investigators use the data pool in order to investigate specific hypotheses and questions.
Eligibility Criteria
Inclusion Criteria: * A) Patients with chronic liver disease and histologically proven cirrhosis * B) Control subjects with no signs of cirrhosis Exclusion Criteria: * Age \<18 years * patients who developed hepatocellular carcinoma (HCC) and/or cholangiocellular carcinoma (CCC)
Contact & Investigator
Christine Bernsmeier, Prof. Dr. med.
PRINCIPAL INVESTIGATOR
University Centre for Gastrointestinal and Liver Diseases, University Hospital Basel, Switzerland
Frequently Asked Questions
Who can join the NCT06092385 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Liver Cirrhosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06092385 currently recruiting?
Yes, NCT06092385 is actively recruiting participants. Contact the research team at christine.bernsmeier@clarunis.ch for enrollment information.
Where is the NCT06092385 trial being conducted?
This trial is being conducted at Lugano, Switzerland, Basel, Switzerland, Bern, Switzerland, Geneva, Switzerland and 6 additional locations.
Who is sponsoring the NCT06092385 clinical trial?
NCT06092385 is sponsored by University Hospital, Basel, Switzerland. The principal investigator is Christine Bernsmeier, Prof. Dr. med. at University Centre for Gastrointestinal and Liver Diseases, University Hospital Basel, Switzerland. The trial plans to enroll 3,000 participants.